United States · FDA National Drug Code directory
Adderall
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57844-110_79af1dc6-c7cf-41b1-a750-e9b47c2187ff
- Product NDC
- 57844-110
- Form
- TABLET
- Composition / generic term
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140203
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 2.5 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 2.5 mg/1
- DEXTROAMPHETAMINE SULFATE — 2.5 mg/1
- AMPHETAMINE SULFATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (57844-110-01) · 57844-110-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →